Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 gp120 C5 region is the C-terminal domain of the surface glycoprotein gp120, which plays a critical role in the non-covalent association with the transmembrane glycoprotein gp41 (RCSB PDB 1MEQ; Guilhaudis et al., 2002). This region, along with the N-terminal C1 region, forms a key part of the gp120/gp41 protein-protein interface within the functional envelope (Env) trimer. The stability of this interface is essential for maintaining the virus in its pre-fusion state and for the subsequent conformational transitions triggered by CD4 and co-receptor binding that lead to viral-host membrane fusion (NIH, 2021). Because of its conserved nature and functional importance, the C5 region and the broader gp120/gp41 interface have emerged as significant targets for broadly neutralizing antibodies (bNAbs) such as 35O22 and VRC44 (Huang et al., 2014; Cale et al., 2024). These agents work by stabilizing the Env trimer and sterically hindering the structural rearrangements necessary for infection. Therapeutic challenges include the potential for viral escape through mutations at the interface and the risk of autoimmune responses due to molecular mimicry between the C5 region and human leukocyte antigen (HLA) class I molecules (Eur J Immunol, 1993).
Inhibition of HIV-1 entry by binding to the gp120/gp41 interface, stabilizing the pre-fusion envelope trimer and preventing the conformational changes required for membrane fusion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human immunodeficiency virus 1 envelope glycoprotein gp120 C5 region (gp120 C5).